| 000 | 01141 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250515060751.0 | ||
| 264 | 0 | _c20070322 | |
| 008 | 200703s 0 0 eng d | ||
| 022 | _a1745-8382 | ||
| 024 | 7 |
_a10.1038/ncprheum0434 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBrar, Adarshdip | |
| 245 | 0 | 0 |
_aUnresolved issue: should patients with RA and a history of malignancy receive anti-TNF therapy? _h[electronic resource] |
| 260 |
_bNature clinical practice. Rheumatology _cMar 2007 |
||
| 300 |
_a120-1 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAntirheumatic Agents _xadverse effects |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xcomplications |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadverse effects |
| 650 | 0 | 4 |
_aNeoplasms _xetiology |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
| 700 | 1 | _aHiebert, Timothy | |
| 700 | 1 | _aEl-Gabalawy, Hani | |
| 773 | 0 |
_tNature clinical practice. Rheumatology _gvol. 3 _gno. 3 _gp. 120-1 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/ncprheum0434 _zAvailable from publisher's website |
| 999 |
_c16891543 _d16891543 |
||